Biosimilar infliximab versus originator in Crohn's disease anti-TNF-α naïve and non-naïve patients.

Prz Gastroenterol · 2021 · PMC8456772 · PMID 34584581

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

1.9%), but it did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.